New Monoclonal Antibodies to Mycobacteria

Approximately one third of the world population is infected with Mycobacterium tuberculosis and 10 million new cases occur per year. Diagnosis of active tuberculosis (TB) consists of sputum stain or culture and both methods have poor sensitivities. Rapid and sensitive methods for diagnosis of active TB are sorely needed.

Lipoarabinomannan (LAM) is an abundant and significant surface antigen of this bacterium. It is shed during growth and studies have shown that it can be found in both sputum and urine during active TB disease.

ViroStat has just released two new MabyRab™ Rabbit Monoclonal Antibodies that are specific for Mycobacteria LAM. These new antibodies form a pair for the detection of LAM and are reactive with all strains of Mycobacterium tuberculosis tested. They offer new tools for TB research and potential for rapid detection of this scourge.

These new antibodies join a unique collection of existing Rabbit Monoclonal Antibodies to Candida albicans, Strep A, Strep B, Strep pneumoniae, Aspergillus species and Legionella from ViroStat. Download data sheets for these antibodies at www.virostat-inc.com.

ViroStat is a primary manufacturer, supplying infectious disease reagents to researchers and rapid test manufacturers since 1985.

Contact ViroStat for your free copy of the new Catalogue at 207-856-6620 or click here to view and download it online.